KirkEdwardCahillMD

Physician

Dr. Cahill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
5841 S Maryland Ave
Ste MC7082
Chicago, IL 60637
Phone+1 773-702-6840

Fax+1 773-702-2230

University of ChicagoResidency, Internal Medicine, 2016 - 2019
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2015

PubMed

1 citations
Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy.
Guanghao Liang, Linchen Wang, Qiancheng You, Kirk Cahill, Chuanyuan Chen
Advanced Science. 2023-08-01
20 citations
Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies.
Anand Patel, Kirk E. Cahill, Caner Saygin, Olatoyosi Odenike
Blood Advances. 2021-04-27
13 citations
CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastoma.
David J. Voce, Giovanna M. Bernal, Kirk E. Cahill, Longtao Wu, Nassir Mansour
Scientific Reports. 2021-03-11

Lectures

Outcomes of IDH-Mutated Advanced Phase Ph-Negative Myeloproliferative Neoplasms Treated with IDH Inhibitors
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
A Multi-Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Rela...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018